Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prognostic PET/CT Model in Non Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03199599
Recruitment Status : Unknown
Verified October 2017 by Poitiers University Hospital.
Recruitment status was:  Recruiting
First Posted : June 27, 2017
Last Update Posted : October 11, 2017
Sponsor:
Collaborator:
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
Poitiers University Hospital

Brief Summary:
Prospective validation of a prognostic model based on advanced PET/CT image analysis in non small cell lung cancer

Condition or disease
Non Small Cell Lung Cancer

Detailed Description:
Validation on a prospective cohort of patient of a predictive model for survival based on image derived parameters

Layout table for study information
Study Type : Observational
Estimated Enrollment : 150 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prognostic Positron Emission Tomography/Computed Tomogrpahy Model in Non Small Cell Lung Cancer
Actual Study Start Date : September 1, 2016
Estimated Primary Completion Date : August 31, 2019
Estimated Study Completion Date : August 31, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer




Primary Outcome Measures :
  1. validation of a multiparametric PET/CT prognostic model [ Time Frame: 18 months ]
    overall survival rate



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
150 patients with Non small cell lung cancer undergoing initial staging FDG PET/CT
Criteria

Inclusion Criteria:

  • non small cell lung cancer
  • initial fluorodeoxygluoces (FDG) PET/CT before treatment

exclusion criteria:

  • none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03199599


Contacts
Layout table for location contacts
Contact: Catherine CHEZE LE REST, PhD, MD 33549443331 catherine.cheze-le-rest@chu-poitiers.fr
Contact: Sarah Guyon sarah.guyon@chu-poitiers.fr

Locations
Layout table for location information
France
Chu Poitiers Recruiting
Poitiers, France
Contact: CATHERINE CHEZE LE REST         
Sponsors and Collaborators
Poitiers University Hospital
Institut National de la Santé Et de la Recherche Médicale, France
Investigators
Layout table for investigator information
Principal Investigator: MATHIEU HATT, PhD Institut National de la Santé Et de la Recherche Médicale, France

Layout table for additonal information
Responsible Party: Poitiers University Hospital
ClinicalTrials.gov Identifier: NCT03199599     History of Changes
Other Study ID Numbers: PRINCE
PRT-K15-119 ( Other Grant/Funding Number: INCA )
First Posted: June 27, 2017    Key Record Dates
Last Update Posted: October 11, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Poitiers University Hospital:
PET/CT
image processing
outcome
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms